Clinical Trial Update: A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 pilot trial in poorly differentiated thyroid cancer evaluated correlations with retinoid and PPAR gamma expression; results have been posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poorly Differentiated Thyroid Carcinoma
• Thyroid Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Thyroid Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2014-01-17